Medical treatment of tuberculosis-update 2011 [Medikamentöse therapie der tuberkulose-update 2011]
Date
2011
Authors
von Groote-Bidlingmaier F.
Diacon A.H.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Tuberculosis is the second most common cause of death from an infectious disease after HIV/AIDS and the leading cause of death from an infectious disease in HIV-co-infected patients. Currently, drug susceptible TB is treated with a four drug regimen given over a period of two months followed by two drugs for four months. Drug resistant tuberculosis requires more complex and longer treatment with alternative substances. New antituberculosis drugs are currently being developed and investigated and are urgently needed to treat drug susceptible and drug resistant TB. © 2011 by Verlag Hans Huber, Hogrefe AG, Bern.
Description
Keywords
tuberculostatic agent, drug sensitivity, review, tuberculosis, AIDS-Related Opportunistic Infections, Antitubercular Agents, Drug Administration Schedule, Drug Interactions, Drug Therapy, Combination, Extensively Drug-Resistant Tuberculosis, Humans, Internationality, Microbial Sensitivity Tests, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary
Citation
Therapeutische Umschau
68
7
http://www.scopus.com/inward/record.url?eid=2-s2.0-79960064818&partnerID=40&md5=50b07aa8c00c6a66064378b63278d07e
68
7
http://www.scopus.com/inward/record.url?eid=2-s2.0-79960064818&partnerID=40&md5=50b07aa8c00c6a66064378b63278d07e